StockGlow

Active Biotech AB (publ) (ACTI.ST)

Develops experimental drug treatments for cancer and inflammatory eye diseases.

5.20+0.01%Healthcare
Compare ACTI.ST with
StockGlow Score
28
Leaning Bearish
BearishBullish
1 year ago-68.2%

The outlook

ACTI.ST is trading near the bottom of its 52-week range and below both its 50- and 200-day moving averages, reflecting a bearish lean from a technical standpoint. The average analyst price target sits roughly 381% above the current price, signaling a substantial gap between current levels and consensus expectations. Overall sentiment remains cautious despite the bullish target backdrop.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +381% vs current price
Market cap
$137.1M
52-wk high
17.46
52-wk low
3.70
50-day avg
5.90
200-day avg
5.46
Trailing P/E
—

Similar stocks

BINV.STBioInvent International AB (publ)$23.05-1.28%ORX.STOrexo AB (publ)$14.48-4.11%ATORX.STAlligator Bioscience AB (publ)$0.04-0.95%CANTA.STCantargia AB (publ)$1.89+1.07%IMMU.STMendus AB (publ)$6.89+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy